Increasing success and evolving barriers in the hepatitis C cascade of care during the direct acting antiviral era.
Barriers remain in the hepatitis C virus (HCV) cascade of care (CoC), limiting the overall impact of direct acting antivirals. This study examines movement between the stages of the HCV CoC and identifies reasons why patients and specific patient populations fail to advance through care in a real wo...
Main Authors: | Autumn Zuckerman, Andrew Douglas, Sam Nwosu, Leena Choi, Cody Chastain |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6005558?pdf=render |
Similar Items
-
Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era
by: Sanam Hariri, et al.
Published: (2020-10-01) -
Predicting Treatment Failure for Initiators of Hepatitis C Virus Treatment in the era of Direct-Acting Antiviral Therapy
by: Nadia A. Nabulsi, et al.
Published: (2020-11-01) -
The hepatitis C virus care cascade in the New York City jail system during the direct acting antiviral treatment era, 2014–2017
by: Justin Chan, et al.
Published: (2020-10-01) -
Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy
by: Chung-Feng Huang, et al.
Published: (2020-07-01) -
Causes of treatment failure for hepatitis C in the era of direct-acting antiviral therapy
by: Joaquín Cabezas, et al.